Jeil Pharmaceutical Co.,Ltd (KRX:271980)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,730
-220 (-1.58%)
Apr 2, 2026, 3:30 PM KST

KRX:271980 Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
200,067220,758166,115249,173306,002494,458
Market Cap Growth
27.25%32.90%-33.33%-18.57%-38.11%-45.95%
Enterprise Value
274,605296,796219,930307,855346,161503,450
Last Close Price
13730.0015150.0011400.0017100.0020937.6133666.10
PE Ratio
8.559.44-49.79--
PS Ratio
0.350.390.240.340.420.71
PB Ratio
0.800.880.761.461.872.96
P/TBV Ratio
0.991.090.911.621.993.01
P/FCF Ratio
-----35.94
P/OCF Ratio
--51.70--25.89
EV/Sales Ratio
0.480.520.310.420.480.72
EV/EBITDA Ratio
8.248.91-16.50--
EV/EBIT Ratio
13.0814.14-34.64--
EV/FCF Ratio
-20.01----36.60
Debt / Equity Ratio
0.370.370.350.420.330.29
Debt / EBITDA Ratio
2.802.80-3.82--
Debt / FCF Ratio
-----3.48
Net Debt / Equity Ratio
0.140.140.080.210.140.12
Net Debt / EBITDA Ratio
1.041.04-2.511.90-5.12-15.87
Net Debt / FCF Ratio
-2.52-2.52-17.13-3.21-0.871.44
Asset Turnover
1.101.101.391.541.641.68
Inventory Turnover
3.393.394.925.195.615.15
Quick Ratio
0.820.820.790.660.710.78
Current Ratio
1.291.291.181.041.121.28
Return on Equity (ROE)
13.61%13.61%-15.45%3.11%-9.06%-8.82%
Return on Assets (ROA)
2.53%2.53%-2.29%1.18%-1.89%-1.55%
Return on Invested Capital (ROIC)
6.79%7.35%-8.36%4.52%-7.13%-5.16%
Return on Capital Employed (ROCE)
7.80%7.80%-7.90%4.90%-6.80%-5.10%
Earnings Yield
11.69%10.59%-18.04%2.01%-4.28%-2.52%
FCF Yield
-6.86%-6.22%-0.64%-4.45%-8.57%2.78%
Dividend Yield
---0.29%0.24%-
Payout Ratio
---14.55%--
Buyback Yield / Dilution
-0.01%-0.01%0.02%0.02%0.23%0.04%
Total Shareholder Return
-0.01%-0.01%0.02%0.31%0.47%0.04%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.